Form 8-K Filing by SkinHealth Systems Inc.

This Form 8-K reports on the events of SkinHealth Systems Inc.'s annual meeting of stockholders held on June 10, 2026. A quorum was present, with approximately 72.08% of the Class A Common Stock represented. Three proposals were voted on: 1. Election of Nine Directors: All nine nominees were elected, with terms expiring at the 2027 annual meeting. 2. Ratification of Appointment of Independent Registered Public Accounting Firm: The appointment of Deloitte & Touche LLP as the independent auditor for the fiscal year ending December 31, 2026, was ratified. 3. Advisory Vote on Executive Compensation: Stockholders approved, on a non-binding advisory basis, the compensation of the named executive officers. The report was signed by Michael Monahan, Chief Financial Officer, on June 16, 2026.